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Abstract
Agonist activation of the hP2Y1 receptor expressed in Xenopus oocytes stimulated an endogenous voltage-gated ion
channel, previously identified as the transient inward (Tin) channel. When human P2Y1 (hP2Y1) and skate P2Y (sP2Y)
receptors were expressed in Xenopus oocytes, time-to-peak values (a measure of the response to membrane
hyperpolarization) of the Tin channel were significantly reduced compared to oocytes expressing the hB1-bradykinin
receptor or the rat M1-muscarinic (rM1) receptor. Differences in activation were also observed in the Tin currents elicited
by various P2Y receptor subtypes. The time-to-peak values of the Tin channel in oocytes expressing the hP2Y4,h P 2 Y 11,
or hB1-bradykinin receptors were similar, whereas the channel had significantly shorter time-to-peak values in oocytes
expressing either the hP2Y1 or sP2Y receptor. Amino acid substitutions at His-132, located in the third transmembrane
domain (TM3) of the hP2Y1 receptor, delayed the onset of channel opening, but not the kinetics of the activation process.
In addition, Zn
2+ sensitivity was also dependent on the subtype of P2Y receptor expressed. Replacement of His-132 in the
hP2Y1 receptor with either Ala or Phe increased Zn
2+ sensitivity of the Tin current. In contrast, truncation of the
C-terminal region of the hP2Y1 receptor had no affect on activation or Zn
2+ sensitivity of the Tin channel. These results
suggested that TM3 in the hP2Y1 receptor was involved in modulating ion channel function and blocker pharmacology of
the Tin channel.
Introduction
Nucleotides, including ATP and UTP, are released from
most cells and function as extracellular signaling molecules
in a variety of cell types. Their biological effects are
mediated through P2 receptors, which are divided into two
classes: Ionotropic P2X receptors and metabotropic P2Y
receptors [1–4]. Eight mammalian P2Y receptors (P2Y1,
P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, P2Y13, and P2Y14) have
been cloned and characterized functionally [4–9]. P2Y1,
P2Y2, P2Y4, and P2Y6 receptors are known to couple
solely to activation of phospholipase C through Gq/11 (and
possibly Gi) resulting in production of IP3 and mobilization
of intracellular Ca
2+ [10–13]. The sP2Y receptor, which
has 61%–64% sequence similarity to the hP2Y1 receptor,
activates Gq/phospholipase C with similar rank nucleotide
selectivity as that of the hP2Y1 receptor [14]. The hP2Y11
receptor activates both phospholipase C and adenylyl
cyclase [15], whereas P2Y12, P2Y13, and P2Y14 receptors
are coupled exclusively to Gi and inhibition of adenylyl
cyclase [5, 7, 16].
Agonist activation of the hP2Y1 receptor expressed in
Xenopus oocytes stimulated a previously characterized
transient inward (Tin) current [17, 18]. The channel
responsible for the Tin current has not been cloned, but
appears to represent a new family of ion channels that has
not been previously characterized at the molecular level.
The Tin current was initially identified following injection
of mRNA from rat brain [19] and subsequently observed
when cloned 5-HT1a and 5-HT2c receptors were expressed
in oocytes [20]. Tin activation required both membrane
hyperpolarization and an increase in intracellular calcium
in addition to agonist activation of these receptors [19, 20].
The Tin channel can be distinguished from endogenous
Ca
2+ and hyperpolarization-activated Cl
j channels in
Xenopus oocytes by its inactivation gating which occurs
within 4 s following hyperpolarization [21]. Moreover,
expression of Gaq in stage V and VI oocytes was found to
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onstrating a role for Gaq in regulation of this channel [22].
We showed recently that P2Y receptors are capable of
activating and modulating the voltage dependence and
inactivation of the Tin channel through interactions involv-
ing the C-terminal domains of these receptors that was
independent of PDZ-binding motifs [18, 23]. In the present
study, we investigated the role of TM3 of the hP2Y1
receptor in modulation of the Tin channel. Our results
indicated that activation and Zn
2+ sensitivity were depen-
dent on the subtype of P2Y receptor expressed and that
mutations within TM3 of the hP2Y1 receptor significantly
altered these properties of the channel.
Materials and methods
Materials
Xenopus laevis frogs were purchased from Xenopus I( A n n
Arbor, Michigan, USA) and maintained in aquaria as
suggested by the supplier. Collagenase and gentamicin
were obtained from Invitrogen (Carlsbad, California,
USA). 2Methylthio-ADP (2MeS-ADP) and 2Methylthio-
ATP (2MeS-ATP) were obtained from Research Bio-
chemicals (Natick, Massachusetts, USA). Carbachol and
bradykinin were obtained from Sigma-Aldrich (St. Louis,
Missouri, USA).
Site-directed mutagenesis
Site-directed mutagenesis was done with the Altered Sites
in vitro mutagenesis system kit from Promega (Madison,
Wisconsin, USA) following the manufacturer’s instructions.
Oocyte isolation and cRNA injections
Ovarian lobes from adult X. laevis frogs were removed
from anesthetized animals under sterile conditions and the
tissue mass was dissociated with collagenase solution (in
mM: 90 NaCl, 1 KCl, 0.82 MgSO4, 10 HEPES (pH 7.4),
250 U/ml collagenase). Stage V and VI oocytes were
sorted, defolliculated and maintained in modified Barth’s
saline solution (MBS solution; in mM: 90 NaCl, 2 KCl,
0.82 MgSO4, 0.74 CaCl2, 10 HEPES, pH 7.4, supple-
mented with 0.05 mg/ml gentamicin) at 19–20 -C. cRNA
was synthesized using the Ambion Megascript Kit (Austin,
Texas, USA) from linear cDNA encoding the hB1-
bradykinin receptor, wild-type P2Y receptors or mutants
of the hP2Y1 receptor. Oocytes were injected with cRNA
transcripts (46 ng/oocyte) using a Drummond Nanoject
oocyte injection system. Control oocytes were injected
with 46 nl of sterile water. Oocytes were stored for 2–7
days in MBS solution.
Electrophysiological measurements
Electrophysiological measurements were made using the
two-electrode voltage clamp technique at 20 -C. Record-
ings were performed in Cl
j-free MBS solution (in mM):
90 NaMeSO4, 2 KMeSO4, 0.82 MgSO4, 0.74 CaGluconate,
10 HEPES (pH 7.4). Electrodes were placed in a separate
Cl
j containing MBS solution and connected to the oocyte
bathing solution with an agar bridge. Current and voltage
measuring electrodes were pulled from borosilicate fila-
ment glass to resistances between 2 and 5 MW when filled
with 0.5 M KCl. Data acquisition and analysis was
performed using pCLAMP 8 software (Axon Instruments,
Union City, California, USA).
Agonist stimulation of expressed receptors
Agonist concentrations used for these experiments were
selected to produce maximum receptor activation, based on
previous concentration–response studies on P2Y receptors
expressed in Xenopus oocytes [17]. Agonists were first
added to the bathing solution to activate the receptors
and then the membrane potential was stepped from 0 to
j140 mV to activate the Tin channel. Maximum current
responses to the voltage step protocol were achieved within
5 min after agonist addition to the bathing solution. 2MeS-
ADP (20 mM) was used to stimulate hP2Y1, mutants of
hP2Y1, and sP2Y receptors. 2MeS-ATP (40 mM) was used
to stimulate hP2Y11 receptors. Bradykinin (2 mM) and
carbachol (10 mM) were used to stimulate hB1-bradykinin
and rM1-muscarinic receptors, respectively.
Analysis and statistics
Statistical significance was determined using Student’s
t-test. Statistical significance was accepted at P-values
G0.05. Conductance–voltage relationships were analyzed
using a Boltzmann function Y = 1/1 + exp(V50 j X/slope
factor), where V50 represents the voltage at which the
conductance is half-maximal, slope factor represents the
degree of voltage dependence (steepness of the curve),
Y represents the normalized conductance, G/Gj140 mV, and
X represents a specific voltage). IC50 values were calcu-
lated using four-parameter logistic function (Y = 100/
(1 + exp (log IC50 j X)  slope)), where X is the
logarithm of concentration and Y is the response.
Results and discussion
Tin channel activation following stimulation of Gq coupled
receptors expressed in Xenopus oocytes
Time-to-peak measurements were used as an indicator of
the activation time course and were defined as the time
between the capacitance current and the peak inward
current (Figure 1A). It is important to note that the time-
to-peak measurement does not reflect the time course of
agonist binding or receptor activation, but instead is a
measure of the time course of channel opening following
the voltage step. When the hP2Y1 receptor and sP2Y
receptor were expressed in Xenopus oocytes, the time-to-
peak activation of the Tin channel at all voltages tested was
76 S.Y. Lee et al.significantly reduced compared to oocytes expressing the
hB1-bradykinin receptor or Gqa subunit (Figure 1B). In
contrast, when either rM1-muscarinic, hP2Y4, or hP2Y11
receptors were expressed in oocytes, time-to-peak values of
the Tin channel were similar to those of hB1-bradykinin
receptor or Gqa subunit but significantly different from
hP2Y1 or sP2Y receptors (Figure 1C). These results
indicated that hP2Y1 and sP2Y receptors were capable of
decreasing the time interval between the initiation of
membrane hyperpolarization and the beginning of Tin
channel opening compared to other Gq coupled receptors,
including other subtypes of P2Y receptors and the Gqa
subunit. Expression of hP2Y1 or sP2Y receptors did not
affect the rate of channel opening, as reflected by the slope
of the current trace between the point of initiation and the
peak inward current, compared to the hB1-bradykinin
receptor (data not shown). These findings suggest that,
unlike hB1-bradykinin or rM1-muscarinic receptors, an
interaction occurs between the hP2Y1 (or sP2Y) receptor
and the Tin channel that influences the ability of the
channel to respond to membrane hyperpolarization.
Effect of C-terminal domain truncation
We showed previously that the C-terminal domain of the
P2Y1 receptor was involved in modulating the voltage
dependence of activation of the Tin channel in Xenopus
oocytes [18]. To determine whether the C-terminal domain
of the hP2Y1 receptor was also involved in modulating
activation, we compared the time-to-peak currents of the
Tin channel in oocytes expressing either the wild-type
hP2Y1 receptor or one of several C-terminal truncation
mutants of the hP2Y1 receptor (Figure 2A). As shown in
Figure 2B, the time-to-peak values of the Tin channel in
oocytes expressing any of the truncation mutants were not
Figure 1. Effects of expressed Gq coupled receptor stimulation on
hyperpolarization-induced activation of the endogenous Tin channel in
Xenopus oocytes. A) Representative trace of the Tin channel current at
j140 mV following stimulation of the expressed hP2Y1 receptor. Time-
to-peak current measurements were used to assess hyperpolarization-
induced activation of the channel and are defined as the elapsed time
following the capacitance current to the peak inward current. B)
Comparison of time-to-peak measurements for hB1-bradykinin (n=13),
Gq alpha subunit (n=13), hP2Y1 receptor (n=14), and sP2Y (n=13).
C) Comparison of time-to-peak measurements for hB1-bradykinin
(n=13), rM1-muscarinic (n=12), hP2Y4 (n=12), and hP2Y11 (n=13)
receptors.
Figure 2. Effect of C-terminal domain truncation on channel activation.
A) The relative locations of TM3 mutations (hP2Y1-H132A, hP2Y1-
H132D, and hP2Y1-H132F) and C-terminal truncation sites within the
hP2Y1 receptor are indicated. B) Comparison of time-to-peak measure-
ments for hB1-bradykinin (n=13), hP2Y1 (n=14), hP2Y1334tr (n=9),
hP2Y1342tr (n=15), hP2Y1349tr (n=11), hP2Y 1360tr (n=15), and
hP2Y1369tr (n=13) receptors as the function of voltage.
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oocytes expressing the wild-type hP2Y1 receptor, suggest-
ing that the C-terminal domain was not involved in
modulating activation of the channel.
Effect of the TM3 mutations on activation and
conductance–voltage relationships
The P2Y1 receptor contains a unique histidine residue at
position 132 that is not present in other P2Y receptor
subtypes. To determine if TM3 of the hP2Y1 receptor is
important in modulating activation, we mutated His-132 to
alanine (hP2Y1-H132A), aspartic acid (hP2Y1-H132D),
and phenylalanine (hP2Y1-H132F) (Figure 2A), expressed
the mutants in Xenopus oocytes, and determined the time-
to-peak value of the Tin current following receptor activa-
tion. Time-to-peak current measurements of all TM3 point
mutations were significantly increased compared to the
wild-type hP2Y1 receptor (Figure 3A). Mutation of His-
132 to alanine, aspartic acid, or phenylalanine increased
time-to-peak current values compared to the wild-type
hP2Y1 receptor, suggesting that the primary structure of
TM3 plays a role in modulating channel activation. It is
worth noting that TM3 of the hP2Y1 receptor is known to
be important in agonist recognition [24–26]. The H132A
mutation was previously shown to produce a shift in the 2-
MeS-ADP EC50 for phospholipase C activation from 1.94
Table 1. V50 and slope factors of Tin currents elicited by agonist-activated
receptors.
Receptors V50 (mV) Slope factor
hB1 (n=13) j43.0 j13.4
hP2Y4 (n=9) j53.8 j18.8
rM1 (n=16) j51.8 j16.2
hP2Y1 (n=13) j72.5* j18.5
hP2Y1-H132A (n=5) j73.7* j18.2
hP2Y1-H132D (n=6) j80.3* j17.3
hP2Y1-H132F (n=5) j69.5* j12.3
V50 is defined as the voltage at which the currents fell to one-half of the
current at j140 mV (see Materials and methods for details).
* The value was significantly different (PG0.05) from the hB1-bradykinin
receptor value.
Figure 4. Effects of Zn
2+ on the inward currents elicited by step
hyperpolarization to j140 mV. A) Representative current traces showing
Tin currents activated by hP2Y1 receptor in the presence of 20 mM 2MeS-
ADP. Agonist-stimulated inward current was inhibited by ZnCl2 in a
concentration-dependent manner. B) Concentration–response relationship
for Gq (n=7) and hB1-bradykinin (n=5). C) Inhibition of hP2Y1 (n=6),
sP2Y (n=5), and hP2Y11 (n=5) receptor-elicited Tin currents by [Zn
2+].
The IC50 values are listed in Table 2.
Figure 3. Effect of third transmembrane domain mutations on activation
and conductance voltage relationships. A) Time-to-peak measurements
for hB1-bradykinin (n=13), wild-type hP2Y1 (n=14), hP2Y1-H132A
(n=5), hP2Y1-H132D (n=7), hP2Y1-H132F (n=10), and hP2Y1-Q307K
(n=7) receptors as a function of voltage. B) Normalized conductance-
voltage relationships for hB1-bradykinin (n =13), wild-type hP2Y1
(n=13), hP2Y1-H132A (n=15), hP2Y1-H132D (n=6), and hP2Y 1-
H132F (n=6). The V50 values and slope factors for each conductance
are listed in Table 1.
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To ensure full activation of the H132 mutant receptors, the
2MeS-ADP concentration used in these experiments was
set at 20 mM.
We also analyzed the conductance–voltage properties of
the Tin channel currents activated by the mutant receptors.
As shown in Figure 3B, the conductance–voltage relation-
ships for these mutants were not significantly different
from the wild-type hP2Y1 receptor. The V50 values, which
are defined as the voltages at which the current is one-half
of that at j140 mV (see Materials and methods for more
details), for each of the hP2Y1 receptor mutants were
similar to the V50 value of wild-type hP2Y1 receptor, but
were significantly more negative than the V50 value
measured for the hB1-bradykinin receptor (Figure 3B,
Table 1). These data demonstrated that the point
mutations in TM3 of the hP2Y1 receptor did not modu-
late the voltage sensitivity of the Tin channel, as was pre-
viously shown for the C-terminal domain of the receptor
[18, 23].
Effects of Zn
2+ on the inward current elicited by step
hyperpolarization to j140 mV
Divalent cations have been shown previously to block
Tin currents, with Zn
2+ being the most potent of these
blockers [17, 19]. Therefore, ZnCl2 was used to compare
divalent ion sensitivity of the Tin current activated by
hB1-bradykinin and P2Y receptors. Figure 4A shows the
current response at j140 mV of the Tin channel elicited
by agonist-activated hP2Y1 receptors in the presence of
increasing concentrations of ZnCl2. The amplitudes of the
Tin currents were reduced in a concentration-dependent
manner in the range of 1 to 500 mMZ n C l 2. Curves were
analyzed by using a four-parameter logistic function as
described in Methods. The IC50 value of ZnCl2 at the Tin
channel activated by the hB1-bradykinin receptor was
65 mM, which was not significantly different from IC50
values obtained following activation by the Gqa subunit
(98 mM; Figure 4B, Table 2) or hP2Y11 receptor (83 mM;
Figure 4C, Table 2). It is worth noting that the inhibition
of Tin channel current by ZnCl2 in oocytes expressing
the Gqa subunit indicated that the effect of Zn
2+ was not
on receptor-mediated regulation of the Tin channel. In
contrast, the IC50 of ZnCl2 for inhibition of Tin currents
activated by the hP2Y1 receptor was significantly higher
(Figure 4C, Table 2). The Zn
2+ IC50 for inhibition of the
currents elicited by the sP2Y receptor, which also has a His
residue at position 132, was essentially identical to that of
hP2Y1 receptor.
To investigate whether His-132 is important in modu-
lating the Zn
2+ sensitivity of the Tin current, we examined
the effect of hP2Y1-H132A and hP2Y1-H132F mutations
in the hP2Y1 receptor on Zn
2+ sensitivity of the channel
(Figure 5A). The Zn
2+ IC50 values for currents elicited by
either the hP2Y1-H132A or the hB1-bradykinin receptor
were similar, whereas the IC50 value of Zn
2+ for currents
elicited by wild-type hP2Y1 receptor was significantly
higher. In contrast, the hP2Y1-H132F receptor-activated
current was considerably more sensitive to Zn
2+ compared
to wild-type hP2Y1 and the hP2Y1-H132A receptors
(Figure 5A, Table 2), suggesting that mutations in the
TM3 alter both Zn
2+ sensitivity of the Tin channel and
activation. A significant change in the slope of the
concentration–response relationship was also observed
following stimulation of the hP2Y1-H132F receptor. This
Figure 5. Effects of Zn
2+ on the inward currents elicited after
stimulation of mutant P2Y1 receptors. A) Inhibition of hP2Y1 (n=6),
hP2Y1-H132A (n=3) and hP2Y1-H132F (n=5) receptor-elicited Tin
currents by [Zn
2+]. B) Inhibition of hP2Y1 (n=6), hP2Y1342tr (n=9),
and hP2Y1-Q307K (n=5) receptor-elicited Tin currents by [Zn
2+]. The
IC50 values are listed in Table 2.
Table 2. IC50 values from Zn
2+ concentration–response relationship in
Figure 4.
Receptors IC50 (mM)
hP2Y1 (n=6) 187
hP2Y11 (n=4) 83*
sP2Y (n=5) 170
HP2Y1-H132A (n=3) 87*
HP2Y1-H132F (n=5) 13*
hB1 (n=5) 65*
Gq (n = 7) 98*
* The value was significantly different (PG0.05) from the hP2Y1 receptor
value.
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2+ sensitivity of
the channel and a dramatic shift in the threshold for Zn
2+
inhibition of the channel. In contrast, C-terminal truncation
nor the hP2Y1-Q307K mutation (an amino acid substitution
in TM7) had no effect on Zn
2+ sensitivity of the Tin
channel (Figure 5B).
Taken together, the results of this study and our
previous work [18] suggest the hypothesis that hP2Y1
and sP2Y receptors interact with the Tin channel at
multiple sites, including their C-terminal tails and TM3
regions. Whereas the C-terminal tails appeared to be
involved in voltage dependence and inactivation kinetics
of the Tin channel, the TM3 region appeared to affect the
response of the channel to membrane hyperpolarization
and ZnCl2 sensitivity. The point mutations in TM3 might
alter a direct interaction of the receptor with the channel or
indirectly affect coupling between the receptor and the
channel at a site other than the TM3 domain through
changes in receptor tertiary structure. It is clear from these
studies, however, that the C-terminal domain of the
receptor does not influence hyperpolarization-induced
activation or Zn
2+ sensitivity. Moreover, activation and
Zn
2+ sensitivity were not affected by expression of the
hP2Y11 receptor, even though this receptor subtype was
shown previously to produce a shift in the voltage
dependence of the channel similar to the hP2Y1 and sP2Y
receptors [18]. This observation is consistent with the idea
that the C-terminal region and TM3 domains of the
receptor independently affect distinct functional properties
of the Tin channel.
Analysis of the hP2Y11 receptor sequence showed that
the corresponding residue to His-132 in TM3 is Thr-107.
It is interesting to note that the Zn
2+ IC50 values for
the Tin currents elicited by hP2Y11, hP2Y1-H132A, and
hB1-bradykinin receptors were not significantly different,
suggesting that the presence of His at this position is
essential for producing the wild-type hP2Y1 receptor effect
on Zn
2+ inhibition of the channel. A similar case can be
made for hyperpolarization-induced activation, in that the
hP2Y11 receptor exhibited properties that were significant-
ly different from the wild-type hP2Y1 receptor but similar
to the hB1-bradykinin receptor.
The results reported in this study and our previous work
suggests that certain P2Y receptors are capable of
modulating ion channel function through membrane-
delimited interactions that do not appear to be associated
with classical G-protein signaling mechanisms. The obser-
vation that mutations in TM3 produce significant changes
in Tin channel function suggests that receptor TM domains
may participate in channel regulation. Although a specific
molecular interaction between the expressed P2Y receptor
and the Tin channel has yet to be identified, one possible
interpretation of our results might be a physical coupling
between the two proteins. This would explain how
relatively subtle changes in TM3 structure could produce
changes within the Tin channel that lead to altered
activation and Zn
2+ sensitivity. Future experiments will
be necessary to determine the molecular basis of Tin
channel modulation by P2Y1 receptors.
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